Quantitative sensory testing and association with cervical spine radiculopathy disability: Systematic review. by Mansfield, M. et al.
Journal of the Physiotherapy Pain Association Page 33
Quantitative sensory testing 
and association with cervical 
spine radiculopathy disability: 
Systematic review.
Author names and affiliations.
Michael Mansfield MSc BSc (Hons) 1
1 Pain Research Cluster; Ageing, Acute and Long 
Term Conditions Research Group. Institute of 
Health and Social Care, London South Bank 
University, London, United Kingdom (UK).
Email: Michael.Mansfield@lsbu.ac.uk
Twitter: @MM_Physio
Tel: 020 7815 7815
Dr sc hum Jan Vollert MSc BSc 2 3
2 Pain Research, Department of Surgery and 
Cancer, Faculty of Medicine, Imperial College 
London, London, UK.
3 Department of Anaesthesiology, Intensive 




Michael Thacker PhD MSc Grad Dip Phys Grad 
Dip MNMSD 1
1 Pain Research Cluster; Ageing, Acute and Long 
Term Conditions Research Group. Institute of 





Michael Mansfield MSc BSc (Hons)
Pain Research Cluster; Ageing, Acute and Long 
Term Conditions Research Group. Institute of 
Health and Social Care, London South Bank 




• First systematic review investigating the association 
between quantitative sensory testing (QST) and disability 
in adults with cervical spine radiculopathy
• From four studies, there was no association between QST 
and disability
• There is a need to complete prospective studies investigating 




Cervical spine radiculopathy (CSR) is a complex clinical 
presentation that can have negative impacts on a person’s 
physical and mental health and wellbeing and engagement with 
activities of daily living. Somatosensory phenotypes of CSR 
can be assessed through quantitative sensory testing (QST). 
However, to date no systematic review has been undertaken 
to determine the association between QST and disability in 
individuals with CSR. Accordingly, this present study sets out 
to investigate this.
Design
A systematic review was conducted including searches of 
PubMed (MEDLINE), EMBASE and CINHAL from inception 
to 22 March 2020. Quantitative studies investigating CSR 
populations with QST measurements and association with 
disability were included. One reviewer conducted the search 
strategy. Two reviewers independently assessed eligibility 
of all search results and completed methodological quality 
assessment using a modified Downs and Black checklist. Data 
were analysed narratively.
Results
Four studies were eligible for inclusion in the final review. The 
quality of these studies was high. There were no statistically 
significant associations between QST and disability among 
people with CSR.
Conclusions
This systematic review fulfilled the aim of investigating the 
association between QST and disability in people with CSR. 
From the four studies included for review, no study reported 
an association. Future research is required to standardise CSR 
diagnostic criteria. QST protocols and further prospective 
studies involving patients are likely to enhance our 
understanding of the clinical presentation of CSR. Key words
Cervical spine radiculopathy; Quantitative sensory testing; 
Disability; Systematic review
Cervical spine radiculopathy (CSR) prevalence values range 
between 1.2 to 5.8 per 1000 people and incidence rates 
range between 0.8 and 1.8 per 1,000 person‐years (1-5). CSR 
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is known to have negative impacts for individuals, families, 
societies and healthcare systems (6-8). It has a complex clinical 
presentation with variable phenotype expression (9, 10), 
resulting in a substantial challenge for clinicians to assess and 
manage optimally (7, 11). CSR is often associated with multiple 
overlapping co-morbidities including (but not limited too) 
psychosocial factors such as depression and anxiety symptoms 
(12-14), There is also an association between sedentary 
lifestyle, CSR and challenges performing daily activities (15, 
16). These factors may result in increased pain and disability 
for individuals. Disability, as defined by the International 
Classification of Functioning, Disability and Health (ICF), 
is an umbrella term for impairments (for example limb 
movement); activity limitations (for example walking) and/
or participation restrictions (for example engagement in 
employment) (17). Disability refers to the negative aspects of 
the interaction between an individual (with a health condition) 
and their contextual factors (environmental and personal) (17).
CSR is defined as a mechanical block to a spinal nerve or root 
through compression, or indirect interruption of nutrition or 
blood supply to a nerve axon or its root (18). In clinical practice 
there is no definitive reference test to diagnose CSR (19, 20), 
nevertheless, clinicians will typically complete a detailed 
subjective assessment listening to the patient narrative around 
symptom description, location and possible psychosocial 
impacts to their activities of daily living (11, 21, 22). Physical 
assessment can determine whether there is a loss of sensory, 
motor function and/or any activity impairments of disability, 
which may or may not be associated with complaints of pain 
by the individual (18). Subjective sensations of paraesthesia, 
hyperaesthesia, dysaesthesia and/or allodynia, confirmed 
objectively by neurological examination, quantitative sensory 
testing (QST) and/or electrodiagnostic testing, occurring in 
the distribution of a spinal nerve are typical (22-25).
Identifying mechanism-based phenotypes of neuropathic 
pain states (including spinal radiculopathy) may optimise 
the diagnosis classification and subsequent management 
strategies (26-28). There is evidence suggesting lower thresholds 
to thermal, mechanical and vibration detection for individuals 
with neuropathic pain presentations such as peripheral 
neuropathy (for example diabetes), carpal tunnel syndrome 
(29) and other spinal musculoskeletal disorders, for example 
cervical spine pain (30). Furthermore, lower threshold to 
thermal and mechanical pain detection thresholds are also 
reported (31).
The complexity in the classification of pain is widely reported 
(32-37), which impacts the clinical assessment of pain conditions 
(32, 35, 38). Clinical impressions (diagnosis) and prognosis 
formulation is based on signs and symptoms and, where 
available, the use of imaging and electrophysical testing (for 
example nerve conduction tests). However, this provides 
limited insight to a patient’s underlying pain mechanisms, 
sensory experience, and daily activities participation. 
Identifying mechanism-based phenotypes in people with CSR 
may enhance the diagnosis classification and subsequently 
enrich our understanding of this complex presentation (26, 
39-41). QST provides enhanced understanding of sensory 
phenotypes of underlying pain mechanisms and is well 
validated (42-44). This form of psychophysical testing procedure 
provides unique information about the functional status 
(hypo/hypersensitivity) of a person’s somatosensory system. 
It is reported that hyper or hypo somatosensory function 
has associations with disability in musculoskeletal conditions 
(for example spinal pain) (45) and peripheral neuropathy 
presentations (for example carpal tunnel) (46). This form of 
psychophysical testing has promising potential to improve CSR 
diagnosis (and other peripheral neuropathy presentations) 
by identifying specific mechanisms of pain and sensory 
experiences alongside our clinical reasoning frameworks (26, 
44, 45). To date, no systematic review has been conducted to 
investigate the possible association between disability and 
cervical spine radiculopathy. An enhanced understanding of 
the relationship between somatosensory function, sensitivity 
and disability could further support clinicians identifying 
phenotypic sub-groups, monitor symptom progression and 
subsequently enhance prognosis formulation. Accordingly, the 
primary aim of this review was to investigate the association 
between QST outcomes and disability in adults with CSR.
Methods
The systematic review was registered with PROSPERO 
review database (Ref: CRD42018103878). The PRISMA 
guidelines of reporting (47) were followed.
Search Strategy
One reviewer (MM) conducted the systematic search of 
electronic databases PubMed (MEDLINE), EMBASE and 
CINAHL from inception to March 22nd 2020. Figure 1 
reports an example of the search strategy used in MEDLINE. 
Hand searches of reference lists and contacting lead authors 
of included articles was completed to determine if there were 
any pending article publications in this area or unpublished 
work identified. An unpublished (grey) literature search and 
trial registry search was completed (Search details available on 
request). The following databases were searched: OpenGrey, 
ClinicalTrials.gov, NIHR portfolio and WHO International 
Clinical Trials Registry Platform.
Eligibility Criteria
Studies were included if they met the following criteria:
a) Adult participants (over 18 years) with a diagnosis of 
CSR. Diagnosis was made by using a modified version of 
the International Association of Pain (20) radiculopathy and 
radicular pain classifications (23) detailed below (Figure 2).
b) Validated functional status or disability measure.
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c) One or more components of the German Research Network 
on Neuropathic Pain (DFNS) QST testing protocol (42, 48)
d) Studies must be either case control, cross-sectional, or 
cohort study design
e) Published in English (or the availability of an English 
translation).
No restriction on the type of setting or publication date was 
applied to potential studies. Studies were excluded if the 
study population of CSR were related to systemic pathology, 
radiculitis, post-surgery, metabolic causes (for example 
diabetes, pre-diabetes), fracture, myelopathy or upper motor 
neurone pathology.
Study Identification
Based on the eligibility criteria, two reviewers independently 
assessed titles and abstracts of all search results (MM, MT). 
From this, full-text studies from potentially eligible studies 
were retrieved and independent assessment was completed by 
the same two reviewers. Final eligibility was based on a full-text 
assessment. Assessment of reliability (between-reviewer) for 
the eligibility criteria was performed for a random sample of 
10 potentially eligible papers using a weighted Kappa statistic 
(49). The between-reviewer agreement ranged from 90-100% 
across the criteria, with 90% (Kappa: 0.80) for overall 
agreement on eligibility of individual papers (available on 
request). Where there were any disagreements an experienced 
researcher (JV) acted as adjudicator. All disagreements were 
resolved through discussion and consensus between MM and 
MT.
Data Extraction
Data were extracted into a pre-defined data extraction table 
independently by two reviewers (MM, JV). Where there 
were any disagreements an experienced researcher acted 
as adjudicator (MT). Consensus was achieved on all data 
extraction points through discussion between MM and JV. 
Data extracted included: study characteristics, participants 
(number, age and gender), population setting, CSR definition, 
disability measure and QST components and outcomes. 
Corresponding authors were contacted to seek clarification 
or to request additional information on the data sets.
Quality Assessment
Two authors (MM, MT) independently assessed the 
quality of each included study using a modified Downs and 
Black checklist (36). This tool is reported to be a valid and 
a reliable critical appraisal tool to assess methodological 
quality of non-randomised control studies (50), which was 
the predominant study design amongst our eligible papers. 
Any disagreement between reviewers in respect of study 
eligibility, data extraction or critical appraisal was firstly 
discussed between the two reviewers (MM and MT). If a 
consensus could not be reached a third reviewer (JV) acted 
as adjudicator.
Criterion 4, 8, 13 and 14 from the Downs and Black 
assessment tool were removed as our research question was 
not addressing interventions or their adverse effects. Criteria 
15 was removed as the research question did not require 
blinding of assessors to an intervention. Item 19 was removed 
as compliance was not an objective of the research. Items 
23 and 24 were removed from assessment of all studies as 
randomisation was not indicated in the study designs.
Data Analysis
Heterogeneity of the included studies was assessed by 
two reviewers (MM, JV) through examination of the data 
extraction table. This demonstrated heterogeneity with CSR 
diagnostic criteria, disability outcome measures and QST 
data presentation. It was therefore inappropriate to conduct 




One thousand nine hundred thirty-nine and 57 records were 
retrieved from the electronic data base and grey literature 
searching, respectively. One thousand eight hundred and 
thirty-four records were subsequently screened when 
duplicate records were removed. Thirty-two full text articles 
were retrieved and assessed for eligibility. A total of six studies 
met the inclusion criteria (Figure 3). However, one study was 
excluded as on further investigation the population did not 
match our inclusion criteria (51). Two studies samples were 
recruited for concurrent studies (30, 52). The characteristics and 
data collection methods were identical across both studies. 
Consequently, one (52) was excluded following discussion and 
agreement across all authors (MM, JV, MT). Accordingly, four 
studies were included for review (30, 31, 53, 54)
Study Characteristics
A total of 95 subjects were sampled across the included studies. 
The characteristics of the four included studies are presented 
in Table 1. Three studies were cross sectional design (31, 53, 54) and 
one study was an age matched cohort design (30). One study 
sampled from primary practice through media advertisement 
(newspaper, social media) (53) and three studies from specific 
tertiary referral pain clinics through convenience sampling (30, 
31, 54). Two studies used the Neck Disability Index (NDI) (30, 53), 
one study used the Pain Disability Index (PDI) (54), and the 
Disability of Arm, Shoulder and Hand (DASH) was used by 
one study (31) to measure disability.
Quality Assessment (Risk of bias)
The scoring between the two reviewers of the included 
studies (Supplementary table 1) had an agreement rate of 92% 
(92/100). Disagreement on scores were with items 25 and 26 
and final agreement was reached on all items after discussion. 
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Three studies scored 95% and one study scored (90%).
Definition of Cervical Spine Radiculopathy (CSR)
One study used self-reported pain and/or other sensory or 
motor dysfunction symptoms below the elbow to confirm 
radiculopathy (53). Two studies combined clinical assessment 
findings (diminished/absent reflexes, myotomal weakness 
and/or sensory deficits to touch and vibration) and confirmed 
C6 or C7 nerve root compromise on imaging (30, 31). One study 
also used this criteria but a positive upper limb neurodynamic 
test was included in their confirmation of radiculopathy 
(31). One study used self-reported cervical spine pain with 
radiating pain below the elbow (54).
Somatosensory phenotypes and pain sensitivity measurements
One study (30) used the standardised DFNS (42) Quantitative 
Sensory Testing (QST) protocol. The QST protocol included 
warm and cold detection thresholds (CDT, WDT), mechanical 
detection threshold (MDT), mechanical pain threshold (MPT), 
mechanical pain sensitivity (MPS), dynamic mechanical 
allodynia (DMA), wind up ratio (WUR), vibration detection 
threshold (VDT) and pressure pain threshold (PPT).
WDT, CDT and VDT were used across three other studies (31, 
53, 54). PPT was used in two additional studies (53, 54). Warm and 
cold pain thresholds (WPT, CPT) were used in one further 
study (31). Heat pain threshold (HPT), temporal summation 
of pain (TSP) and conditioned pain modulation (CPM) were 
used in one study (54).
Disability Measures
Two studies measured disability through the Neck Disability 
Index (NDI) (30, 53). Mean scores of 37.3 (SD 18.9) and 16.2 (SD 
7.7) were reported for cervical radiculopathy groups from 
Chien et al (2008) (53) and Tampin et al (2012) (30) respectively. 
This represents “complete” (53) and “moderate” (30) disability 
classifications. One study reported a mean score of 42.1 
(SD±4.7) with the Pain Disability Index (PDI) representing a 
“high” level of disability (54). One study reported Disability of 
the Arm and Shoulder Questionnaire (DASH) mean scores of 
30.4 (Inter Quartile Range, 25.3) (31) signifying a “low” level of 
disability among patients with CSR.
Primary analysis: Association between somatosensory 
function and/or pain sensitivity and disability.
Detection threshold
All studies completed cold detection threshold, warm 
detection threshold and vibration detection threshold 
measures in patients with CSR (30, 31, 53, 54). There were no 
statistically significant associations between these detection 
threshold measures and disability outcome measures (NDI and 
DASH). Mechanical detection threshold was measured in one 
study, which reported no statistically significant associations 
between NDI disability measures (30).
Thermal hypo/hyperalgesia
Three studies measured cold pain threshold and heat pain 
threshold (30, 31, 53) and reported no statistically significant 
associations with NDI or DASH disability measures.
Mechanical hypo/hyperalgesia
Two studies completed pressure pain threshold measurements 
at local cervical spine sites (53, 54) and one study completed 
pressure pain threshold at distal sites in a “dermatome zone” 
ipsilaterally and at the same site contralaterally (30). There were 
no statistically significant relationships between pressure pain 
threshold measurements and disability. One study measured 
conditioned pain modulation and temporal summation of 
pain and no statistically significant associations with disability 
scores were reported (54).
Warm detection threshold, cold detection threshold, 
pressure pain threshold and cold pain threshold and disability 
measurements are represented in supplementary figures 1-4.
DISCUSSION
This is the first systematic review of studies assessing the 
association of somatosensory phenotypes measured through 
QST and disability in adults with CSR. There were no 
statistically significant associations between QST and disability 
among patients with CSR.
Each study used variable diagnostic criteria for CSR, 
including a combination of sensory disturbances and/or 
motor weakness confirmed through electrophysical testing or 
manual muscle testing. One study utilised physical assessment 
techniques to confirm CSR among their sample. The variance 
may be attributed to the differences in diagnostic procedures 
and resources across global healthcare systems. It is advocated 
that clinicians continue to use robust patient centred clinical 
reasoning frameworks and use recommended guidelines to 
inform a CSR diagnosis (23, 28, 55).
Identifying somatosensory phenotypes through QST may 
enhance the CSR diagnosis classification and subsequently 
enrich our understanding of this complex presentation (26, 39-41). 
QST methodologies are well validated (42-44), have encouraging 
potential to enhance entrapment neuropathy diagnosis 
(29) and can subsequently inform individualised treatment 
strategies by identifying subgroups of somatosensory 
phenotypes (56, 57). Interestingly, each included study utilised 
different QST procedures to map somatosensory profiles, 
which may be attributed to the resources available and 
experience of conducting testing procedures such as DFNS 
(25). The consistency of QST procedures across entrapment 
neuropathies such as CSR is strongly encouraged for future 
research protocols and clinical practice.
Contrasting the association of spinal pain without 
radiculopathy and disability, may support the contextualisation 
of this review’s findings. A meta-analysis reported that the 
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relationship between pain threshold and pain-related disability 
among individuals with neck and low back pain was weak (58). 
Pain threshold measures explained around 2% of the variance 
in disability and the modality of QST did not predict or inform 
the strength of relationship for both neck and low back pain 
(58). However, these findings were based on pain intensity, 
perception and/or tolerance testing procedures. Further, the 
weakness in association may be attributed, in part, to evoked 
experimental pain testing not representing the same clinical 
pain construct for patients (58).
There are limitations of our systematic review. There were 
six studies that initially met our inclusion criteria. However, 
one study was not included as there was repetition of data. 
On further inspection, one more study did not meet the 
QST inclusion criteria, therefore four studies were included 
in the final review. First, our narrative (descriptive) analysis 
was based on four heterogenous studies (two from Australia, 
one from Denmark and one from Ireland) which limits the 
external validity across other geographical regions. Second, 
the measures of disability varied across the included studies 
and included NDI, DASH and PDI, therefore making a direct 
comparison across disability domains unfeasible. Greater 
consistency between the use of disability measures may 
have enhanced the analysis and improved external validity 
to clinical populations. The patient populations across the 
four studies varied in CSR diagnostic criteria and healthcare 
locations. Greater consistency and enhanced transparency of 
CSR diagnostic criteria may have improved the generalisability 
to clinical practice.
Furthermore, only one study recruited from primary practice 
which limits it application to clinicians working in this setting.
We also acknowledge that association between factors cannot, 
of itself, assume causation. The included studies were cross 
sectional in design where the exposure and outcome are 
simultaneously assessed, this can mean there is generally no 
evidence of a temporal relationship between exposure and 
outcome (59).
Additional research is necessary to advance our understanding 
of QST and its associations with disability in entrapment 
neuropathies such as CSR. The consistency of sensory testing 
protocols and CSR diagnostic criteria should be strongly 
encouraged among researchers and clinicians. Improving 
consistency will enhance diagnosis, care pathways and 
analysis of future reviews including updates to this review. 
Investigating CSR, QST and disability with patients from a 
range of primary healthcare settings and socioeconomic 
environments is necessary to enhance our understanding of 
how it impacts people from differing backgrounds. None 
of our included studies have investigated this impact and 
it may enhance clinical decision making if future studies 
measured health-related quality of life (for example EQ5D). 
It is acknowledged that a full QST protocol is not routinely 
undertaken in a clinical setting. However, modified sensory 
testing assessments (for example light touch, pin prick and 
vibration detection) are used. Further research to enhance 
the clinical utility, reliability and cost of QST is ongoing and 
will enhance clinicians clinical reasoning decisions for this, 
and other, entrapment neuropathy. Future prospective cohort 
study designs assessing natural course and stability of QST and 
disability measurements will also provide valuable insights 
for clinicians managing this complex presentation and policy 
makers evaluating healthcare utilisation.
CONCLUSION
This systematic review fulfilled the primary aim of investigating 
the association between QST outcomes and disability in adults 
with CSR. From the four studies included, no study reported 
statistically significant associations. This may be attributed 
to the limited consistency between QST protocols and CSR 
diagnostic criteria found in these studies. Further research is 
recommended in standardising diagnosis classification criteria. 
In addition, research investigating the relationship between 
QST, pain sensitivity and disability is clearly indicated to 
further our understanding of this condition.
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Figure 1 – MEDLINE search strategy - Completed on 22nd 
March 2020
Radiculopathy: Radiculopathy [MESH] OR Nerve* 
entrapment OR Radicular [MESH] OR Referred pain [MESH] 
OR Brachialgia [MESH] OR Cervicobrachial [MESH] OR 
Upper limb radiculopathy [MESH] OR Neck and arm pain 
[MESH] OR nerve truck [free text] or spinal disease [MESH]
AND
Disabilities of the Arm Shoulder and Hand [MESH] OR 
patient specific functional scale [MESH] OR Northwick Park 
pain questionnaire [MESH] OR Neck disability index [MESH] 
OR SF-36 OR Oswestry [MESH] OR Roland morris OR 
disability [MESH] OR function [MESH]
AND
warm detection OR pain tolerance OR cold pain OR 
heat pain OR temporal summation OR thermal pain OR 
peripheral sensitization OR central sensitization OR pressure 
pain OR hypesthesia OR hyperesthesia OR hyperalgesia OR 
psychophysics OR sensory threshold OR sensory detection 
OR thermal detection OR thermal threshold OR cold 
detection OR heat detection OR pain detection OR pain 
threshold OR sensitivity OR Quantitative sensory test OR 
QST OR Quantitative sensory. [NB. All free text terms]
Figure 2. Modified Radiculopathy 
Diagnostic Criteria
Definite CSR Diagnosis - Either (i) or (ii)
(i) Acute denervation with EMG studies or sensory changes 
in dermatomal distribution
AND
Weakness, atrophy or fasciculation in a myotomal distribution 
and Unilateral diminished deep tendon reflexes
(ii) Abnormal myelography, CT or MRI correlating with 
radiculopathy with neck pain or combined neck and arm pain
OR
Paraesthesia, hyperaesthesia or dysaesthesia in a nerve root 
distribution or muscle weakness in a myotomal distribution 
or atrophy
Probable CSR Diagnosis - Either (iii), (iv) or (v)
(iii) Neck pain, neck and arm pain, paraesthesia, hyperaesthesia 
or dysaesthesia in a nerve root distribution or muscle weakness 
in a myotomal distribution or atrophy
with
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Sensory changes in dermatomal distribution or muscle weakness in a myotomal distribution or atrophy or fasciculation in a 
myotomal distribution or unilateral diminished deep tendon reflexes
(iv) Neck pain, neck and arm pain, paraesthesia, hyperaesthesia or dysaesthesia in a nerve root distribution or muscle weakness 
in a myotomal distribution or atrophy
with
Abnormal myelography, CT or MRI correlating with radiculopathy
(v) Neck pain or neck and arm pain with two from:
(v-i) Sensory changes in dermatomal distribution
(v-ii) Muscle weakness in a myotomal distribution or atrophy
(v-iii) Fasciculation in a myotomal distribution
(v-iv) Unilateral diminished deep tendon reflexes KEY
Reporting: “Yes=1,” “No=0”
1. Is the hypothesis /aim /objective of the study clearly described?
2. Are the main outcomes to be measured clearly described in the Introduction or Methods section?
3. Are the characteristics of the patients / samples included in the study clearly described?
* 4. Are the interventions of interest clearly described? NB NA to all included studies
5. Are the distributions of principal confounders in each group of subjects to be compared clearly described?
“Yes=2,” “Partially=1,” “No=0”
6. Are the main findings of the study clearly described?
7. Does the study provide estimates of the random variability in the data for the main outcomes?
* 8. Have all important adverse events that may be a consequence of the intervention been reported? NB NA to all included 
studies
9. Have the characteristics of patients lost to follow-up been described?
10. Have actual probability values been reported (e.g., 0.035 rather than <0.05) for the main outcomes except where the 
probability value is less than 0.001?
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Full-text articles excluded, 
with reasons 
(n = 28) 
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External validity: “Yes=1,” “No=0,” “Unable to determine=0”
11. Were the subjects asked to participate in the study representative of the entire population from which they were recruited?
KEY
Reporting: “Yes=1,” “No=0”
1. Is the hypothesis /aim /objective of the study clearly described?
2. Are the main outcomes to be measured clearly described in the Introduction or Methods section?
3. Are the characteristics of the patients / samples included in the study clearly described?
* 4. Are the interventions of interest clearly described? NB NA to all included studies
5. Are the distributions of principal confounders in each group of subjects to be compared clearly described?
“Yes=2,” “Partially=1,” “No=0”
6. Are the main findings of the study clearly described?
7. Does the study provide estimates of the random variability in the data for the main outcomes?
* 8. Have all important adverse events that may be a consequence of the intervention been reported? NB NA to all included 
studies
9. Have the characteristics of patients lost to follow-up been described?
10. Have actual probability values been reported (e.g., 0.035 rather than <0.05) for the main outcomes except where the 
probability value is less than 0.001?
External validity: “Yes=1,” “No=0,” “Unable to determine=0”
11. Were the subjects asked to participate in the study representative of the entire population from which they were recruited?
12. Were those subjects who were prepared to participate representative of the entire population from which they were recruited?
* 13. Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients 
receive? NB NA to all included studies
Internal validity - bias: “Yes=1,” “No=0,” “Unable to determine=0”
* 14. Was an attempt made to blind study subjects to the intervention they have received? NB NA to all included studies
15. Was an attempt made to blind those measuring the main outcomes of the intervention?
16. If any of the results of the study were based on “data dredging” was this made clear?
17. In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case-control studies, is 
the time period between the intervention and outcome the same for cases and controls?
18. Were the statistical tests used to assess the main outcomes appropriate?
* 19. Was compliance with the intervention/s reliable? NB NA to all included studies
20.Were the main outcome measures used accurate (valid and reliable)?
Internal validity - confounding (selection bias): “Yes=1,” “No=0,” “Unable to determine=0”
21. Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case-control 
studies) recruited from the same population?
22. Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case-control 
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studies) recruited over the same period of time?
* 23.Were study subjects randomized to intervention groups? NB NA to all included studies
* 24.Was the randomized intervention assignment concealed from both patients and health care staff until recruitment was 
complete and irrevocable? NB NA to all included studies
25. Was there adequate adjustment for confounding in the analyses from which the main findings were drawn?
26. Were losses of patients to follow-up taken into account?
27. Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being 
due to chance is less than 5%?
Supplementary figure 1
37 





Forest plot showing point estimates and inter quartile ranges (IQR) between mean Warm Detection Threshold and disability with interquartile ranges for 
participants with cervical spine radiculopathy. ‘Low’, ‘Moderate’, ‘High’ and ‘Complete’ relate to the disability severity of participants with cervical spine 



































Forest plot showing point estimates and inter quartile ranges (IQR) between mean Warm Detection Threshold and disability 
with interquartile ranges for participants with cervical spine radiculopathy. ‘Low’, ‘Moderate’, ‘High’ and ‘Complete’ relate 
to the disability severity of participants with cervical spine radiculopathy in each included study. The size of the centre point 
corresponds to the sample size within the study.
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Forest plot showing point estimates and inter quartile ranges (IQR) between mean Warm Detection Threshold and disability with interquartile ranges for 
participants with cervical spine radiculopathy. ‘Low’, ‘Moderate’, ‘High’ and ‘Complete’ relate to the disability severity of participants with cervical spine 



































Forest plot showing point estimates and inter quartile ranges (IQR) between mean Warm Detection Threshold and disability 
with interquartile ranges for participants with cervical spine radiculopathy. ‘Low’, ‘Moderate’, ‘High’ and ‘Complete’ relate 
to the disability severity of participants with cervical spine radiculopathy in each included study. The size of the centre point 
corresponds to the sample size within the study.
Supplementary figure 2
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Forest plot showing point estimates and inter quartile ranges (IQR) between mean Pressure Pain Threshold and disability with interquartile ranges for 
participants with cervical spine radiculopathy. ‘Low’, ‘Moderate’, ‘High’ and ‘Complete’ relate to the disability severity of participants with cervical spine 



































Forest plot showing point estimates and inter quartile ranges (IQR) between mean Pressure Pain Threshold and disability with 
interquartile ranges for participants with cervical spine radiculopathy. ‘Low’, ‘Moderate’, ‘High’ and ‘Complete’ relate to the 
disability severity of participants with cervical spine radiculopathy in each included study. The size of the centre point corresponds 
to the sample size within the study.
Supplementary figure 3
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Forest plot showing point estimates and inter quartile ranges (IQR) between mean Cold Detection Threshold and disability with interquartile ranges for 
participants with cervical spine radiculopathy. ‘Low’, ‘Moderate’, ‘High’ and ‘Complete’ relate to the disability severity of participants with cervical spine 
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Centigrade (oC)
Forest plot showing point estimates and inter quartile ranges (IQR) between mean Cold Detection Threshold 
and disability with interquartile ranges for participants with cervical spine radiculopathy. ‘Low’, ‘Moderate’, 
‘High’ and ‘Complete’ relate to the disability severity of participants with cervical spine radiculopathy 









Forest plot showing point estimates and inter quartile ranges (IQR) between mean Cold Pressure or Pain Threshold and disability with interquartile ranges for 
participants with cervical spine radiculopathy. ‘Low’, ‘Moderate’, ‘High’ and ‘Complete’ relate to the disability severity of participants with cervical spine 




































Forest plot showing point estimates and inter quartile ranges (IQR) between mean Cold Pressure or Pain Threshold and disability 
with interquartile ranges for participants with cervical spine radiculopathy. ‘Low’, ‘Moderate’, ‘High’ and ‘Complete’ relate 
to the disability severity of participants with cervical spine radiculopathy in each included study. The size of the centre point 
corresponds to the sample size within the study.
